Detalles de la búsqueda
1.
Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.
Blood
; 118(3): 529-34, 2011 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21482708
2.
Expression of heat shock proteins in classical Hodgkin lymphoma: correlation with apoptotic pathways and prognostic significance.
Histopathology
; 58(7): 1072-80, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21480956
3.
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Lancet Oncol
; 11(10): 934-41, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20739218
4.
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
Haematologica
; 95(11): 1913-20, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20663944
5.
Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response.
Br J Haematol
; 142(5): 766-74, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18637804
6.
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
Haematologica
; 93(4): 560-5, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18322252
7.
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
Haematologica
; 91(5): 621-7, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16627253
8.
Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group.
J Clin Oncol
; 22(9): 1664-73, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15117989
9.
Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Haematologica
; 90(1): 54-9, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15642669
10.
CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Clin Cancer Res
; 10(22): 7599-606, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15569991
11.
[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group]. / Utilización de bisfosfonatos en pacientes con mieloma múltiple: recomendaciones del comité de expertos del Grupo Español de Mieloma del Programa Español de Tratamientos en Hematología.
Med Clin (Barc)
; 134(6): 268-78, 2010 Mar 06.
Artículo
en Español
| MEDLINE | ID: mdl-19863972
12.
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma.
Leuk Lymphoma
; 43(1): 67-74, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11908738
13.
Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience.
Leuk Lymphoma
; 53(9): 1714-21, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22292853
14.
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
Leuk Lymphoma
; 53(5): 812-9, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22185637
15.
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
J Clin Oncol
; 26(35): 5775-82, 2008 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19001321
16.
Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Biol Blood Marrow Transplant
; 13(12): 1448-54, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18022574
17.
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
Blood
; 108(2): 662-8, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16551964
18.
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
Blood
; 108(7): 2165-72, 2006 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16772605
19.
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
Blood
; 106(12): 3755-9, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16105975
20.
Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Haematologica
; 87(6): 609-14, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12031917
Resultados
1 -
20
de 20
1
Próxima >
>>